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Background: The optimal treatment of nonparasitic liver cysts is still a topic of debate. Only symptomatic cysts are
being considered as requiring treatment. Aim of this study is to evaluate our experience with this disease over the
past ten years with a structured follow-up program.
Methods: From January 2000 to August 2010, 56 consecutive patients with nonparasitic liver cysts were treated at
our institution. We assessed morbidity, recurrence and complication rates, quality of life as well as pre- and post-
operative sonographic status of the cysts and course of clinical symptoms.
Results: In 84% of the patients surgery was started as a laparoscopic procedure. Conversion rate was 6.4%. Average
diameter of deroofed cysts was 12 cm. Overall complication rate was 16% and overall recurrence rate 28.3%
(8.7% recurrences at the surgical site, 19.6% new or enlarged cysts). One half of the patients were symptom-free
after surgery and the other half had at least one persisting symptom post-operatively. In one half of these patients
with persisting symptoms, symptoms were ameliorated by surgery. In the other half of patients the number of
symptoms increased after surgery. Two thirds of the overall patients reported their post-operative health as being
good or very good.
Conclusions: Surgical deroofing is the most effective treatment option for symptomatic liver cysts. Half of our
patient population retained at least one symptom from a group of more than ten abdominal symptoms.
Only the minority of these cases may be attributed to true recurrence, de-novo cysts or growing pre-existing cysts.
The analysis of our cases suggests that the persistent symptoms in our patients may in part be due to the fact that
the association between clinical complaints and the liver cysts was not sufficiently established. A more rigid patient
selection should be implemented in order to achieve better results from the treatment of cysts. Because even large
cysts are frequently asymptomatic, patient selection should not primarily be based on the cyst size only. The
decision should be based strictly on the correlation between cyst / cyst location and symptoms / clinical
complaints. In our opinion, further diagnostic procedures may be necessary in individual cases to clarify such a
correlation.Background
Nonparasitic liver cysts occur in up to 5% of the popula-
tion [1,2]. There are simple (single or multiple) cysts (sim-
ple liver cyst, SLC) as opposed to polycystic liver disease
(PCLD). There is currently a general agreement that only
symptomatic cysts should be treated. 10%-16% of patients
with liver cysts develop symptoms at some stage in life
[3]. Symptoms develop at an advanced age and are non-
specific. Women are more frequently affected [4,5]. As the
recurrence rate of percutaneous drainage alone is up to* Correspondence: Hubert.Scheuerlein@med.uni-jena.de
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distribution, and reproduction in any medium100%, this procedure cannot be accepted as the only treat-
ment [6]. For sclerotherapy very heterogeneous success
rates between 0% and 100% are being reported with a low
complication rate and short hospital stay [7]. In a recent
prospective sclerotherapy study in 20 patients with 20%
saline the cysts had completely disappeared after 2 years
follow-up in 40% of the patients [8]. There are no larger
or randomized comparative studies. Thus, sclerotherapy
cannot be evaluated sufficiently with respect to its defini-
tive value as yet. Laparoscopic cyst deroofing is the gold
standard for treatment if this is feasible with respect to the
location and configuration of the cysts [9,10]. Its value,
too, has not been definitively assessed, but there are datantral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 Demographic and clinical characteristics
Male : Female 7:49
Simple liver cysts : Polycystic liver disease 52:4
Age, years (range) 59 (39–81)
BMI, kg/m2 (range) 27 (19–41)
ASA I, n (%) 9 (16)
ASA II, n (%) 42 (75)
ASA III, n (%) 5 (9)
Diameter of dominant cyst, cm (range) 12 (6–20)
Laparoscopic/open deroofing, n (%) 47 (84)/9 (16)
Conversion rate (%) 6.4
Simultaneous cholecystectomy, n (%) 16 (29)*
Postoperative complication rate (%) 16**
Recurrence rate (%) 8.7
*8/47 (17%) laparoscopic, 8/9 (89%) open; **13% laparoscopic, 33% open,
not significant.
Abbreviations: BMI Body Mass Index, ASA American Society
of Anesthesiologists.
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were superior to the open approach [11]. Very heteroge-
neous success rates between 43% and 96% are being
reported [2]. Irrespective of the surgical methods, true re-
currence and growing remnant cysts are frequently re-
ported in the literature. There is no definitive correlation
with clinical symptoms. Studies with a larger sample size
(> 50) and/or specific pre- and post-operative comparison
of symptoms are scarce [2,11]. The value of this present
study lies in its systematic sonografic and clinical follow-
up after surgical cyst deroofing with a large patient popu-
lation and long follow-up period.
Methods
Between January 2000 and August 2008, 56 consecutive
patients with symptomatic nonparasitic hepatic cysts
were evaluated and treated at our institution.
The decision for surgery was generally based on a mini-
mum cyst size of 5 cm and abdominal pain, dyspnea and/
or vegetative symptoms caused by adjacent organ com-
pression or increased abdominal pressure and, therefore,
causing gastrointestinal transport impairments, resulting
in nausea, vomiting, oesophageal reflux, loss of appetite
and/or early satiety. Mainly cysts located on the liver mar-
gin or underneath the surface within the parenchyma of
the segments II, III, IVb, V and VI were selected for lap-
aroscopic surgery.
There were 49 women and 7 men, with a mean age of
59 years (range 39 to 81 years). 4 patients had PCLD. All
patients underwent pre-operative sonography. The echi-
nococcus serology was negative in all cases.
These were the criteria for sonographic evaluation as
benign / non-parasitic liver cyst: smooth margins, no
septum, watery / clear cyst fluid, no contrast enhancement
and calcifications. Further diagnostic procedures were ini-
tiated in cases of even the slightest suspicion of parasitic
or neoplastic cyst.
All operations were performed as deroofing. The de-
cision for open or laparoscopic surgery was made by
the respective surgeon depending on his/her experience,
cyst location and relevant co-morbidities (e.g. vena cava
thrombosis being a contra-indication against the laparo-
scopic technique). The decision whether to perform an
omentoplasty was also made exclusively by the operating
surgeon. For open surgery, access was gained via a J inci-
sion. Laparoscopic surgery was performed via a 3-trocar-
technique in the region of the right hypochondrium (in
individual cases, another trocar was used as auxiliary
trocar). For deroofing, we attempted to remove a max-
imum of the cyst roof (“wide deroofing”). The operating
surgeon decided on the dissection method and in most
cases, ultrasonic dissection was performed (Ultracision
harmonic scalpel, Ethicon Endo Surgery, Norderstedt,
Germany).A specific questionnaire with regard to medical history
(including a detailed history of the medication, paying
special attention to female sexual hormones), symptoms
and quality of life was developed. The patients were
interviewed post-operatively and were asked to compare
their current clinical complaints with the pre-operative
complaints. All patients had additionally been invited for
a sonographic and clinical follow-up examination. The
pre- and post-operative sonographic examination was
standardized on the basis of the Couinaud segment clas-
sification. Statistics were performed with SPSS 18 (chi-
square test, Kruskal-Wallis test, paired t-test, Wilcoxon
test). Patients were analysed regarding demographics,
cyst morphology, symptoms and complaints, therapeutic
procedures, postoperative complications according to
Clavien-Dindo classification and longterm results (syn-
opsis of relevant demographic and clinical characteristics
in Table 1).
An approval of the local ethic’s committee was not
needed in this design, since all patients give their con-
sent to follow-up investigations and further use of their
data when entering our department. Furthermore, the
study design was non-invasive.
Results
General aspects
For pre-operative work-up, 77% of patients had com-
puted tomography in addition to sonography and 5%
had an MRI.
Complete follow-up (sonography, clinical examination
and complete questionnaire) was achieved in 46/51 pa-
tients (90%). The average follow-up period was 43 months
(3–119 months). Four patients had died during follow-up
(the cause of death was not related to the liver cyst or
Table 3 Pre-operative symptoms (multiple answers
permitted)
Symptom n %
Upper abdominal pain 33 58.9
Feeling of pressure 32 57,1
Fullness 8 14,3
Nausea 8 14,3
Weight loss 3 5,4
Vomiting 3 5,4
Dyspnoea 3 5,4
Early satiety 2 3,6
Loss of appetite 2 3,6
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liver transplantation.
The cysts had been known for 40 months on average
(0–360 months). The average BMI was 27 kg/m2 (19–
41 kg/m2). 46/49 women (94%) had given birth. Use of fe-
male sexual hormones postmenopausal or for contracep-
tion was recorded in 22% and 67% of patients, there was
no significant association with symptoms or cyst size. All
surgical samples were examined by the pathologist and
there was no malignancy. 41/56 (73%) did have prior ab-
dominal surgery and 24/49 (49%) female patients did have
prior gynaecological surgery. 18/56 (32%) patients did
have other concomitant diseases of the gastrointestinal
tract (Table 2). As for non-abdominal co-morbidities, these
were mainly cardiac/circulatory (43%) and metabolic (32%).
16/56 (29%) patients had a simultaneous cholecystectomy
(6× gall stones, 9× close proximity to the cyst, 1 both fac-
tors). 7/56 (13%) patients underwent previous treatment
for their cysts elsewhere (5 percutaneous drainages, 1 lap-
aroscopic and 1 open cyst fenestration). 9/56 (16%) patients
were ASA class I, 42/56 (75%) were ASA class II and 5/56
(9%) were ASA class III. There was no surgical mortality.Pre-operative symptoms
The distribution of pre-operative symptoms is shown in
Table 3 (multiple answers possible, minimum number of
symptoms 1, maximum number of symptoms 7).Cyst status
17/52 (33%) patients with SLC had single and 35/52
(67%) had multiple cysts. Of the 4 patients with PCLD 2
had Gigot stage I and 2 had Gigot stage III. Only the left
or the right liver lobe was affected in 7 (13%) and 11
(20%) cases, respectively. In the remaining 38 patients,
both lobes were affected. There was a cyst related hep-
atomegaly in 41% of the patients. The average diameter
of the deroofed cysts was 12 cm (6–20 cm). In one third
of the patients, the segments IVa, VII and VIII were af-
fected (these are considered as being difficult to access









Exocrine pancreatic insufficiency 1
GERD – Gastroesophageal reflux disease.Laparoscopic surgery
In 47/56 (84%) patients surgery was started as a laparo-
scopic procedure. In 3 patients, there was a conversion to
open surgery (conversion rate 6.4%). The reasons for con-
version were hemorrhage (2 cases) and an incidental find-
ing of a peritoneal metastasis from breast cancer (1 case).
The average surgical duration was 80 min (16–230 min).
In cases of simultaneous cholecystectomy (8 cases) the
surgical duration was significantly prolonged, on average
by 20 min (p = 0.014). A mean number of 2 cysts (1–9
cysts) were deroofed. In 5 patients, omentoplasty was
performed. The average post-operative hospital stay was
6 days (4–13 days) following deroofing and cholecystec-
tomy and 5.2 days (2–19 days) after deroofing only, re-
spectively. The difference was not significant (p = 0.291).
Laparotomy
9/56 patients (including 2/4 patients with PCLD, both
stage Gigot I) have had a primary laparotomy. The rea-
sons for primary laparotomy included: cyst-related infer-
ior vena cava thrombosis (2 cases), massive cystic liver
(1 case), recurrence (1 case), previous Billroth-II resec-
tion (1 case), abscess (1 case) and position or morph-
ology of the cysts deemed unfavourable (3 cases). The
mean surgical duration was 106 min (44–173 min). An
average of 2 cysts (1–3 cysts) have been fenestrated.
Omentoplasty was performed in 3 cases. A simultaneous
cholecystectomy was performed in 8 patients. When
compared to the laparoscopic procedure, the post-
operative hospital stay was significantly longer (mean
8.3 days, range 6–21 days; p = 0.004).
Complications
Intraoperative complications
There were 8 intra-operative complications in the lap-
aroscopic group. These were injuries to the liver paren-
chyma (4 cases), one injury to the left hepatic vein, one
hemorrhage during omentoplasty, one bile leak and one
injury to the adrenal gland. The injury to the hepatic
Table 4 Symptom change in patients with persisting
symptoms
Symptom change Number of symptoms Δ (Difference)
Pre-operative→ Post-
operative
No change (n = 3) 2→ 2 0
1→ 1 0
1→ 1 0
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all others were managed laparoscopically. There were no
complications in the laparotomy group. Thus, the total
intra-operative complication rate was 14% (8/56; laparos-
copy group 8/47 (17%), laparotomy group 0/9 (0%)). The
intra-operative complication rate was not significantly dif-
ferent (p = 0.361).
Postoperative complications
The total post-operative complication rate was 16% (9/56;
laparoscopy group 6/47 (13%), laparotomy group 3/9
(33%)). There was a total of 14 complications, including
10 complications according to the Clavien-Dindo classifi-
cation I (5 pleural effusions; ascites, impaired wound
healing, partial respiratory insufficiency, dyspnoea, fever,
one case each), one Clavien-Dindo classification II (urin-
ary tract infection) and 3 cases of Clavien-Dindo classifica-
tion IIIa (bilioma / bile leak). There was a significant
difference between the two surgical techniques (p = 0.031).
Follow-up
Immediate post-operative sonography
In 50/56 (89%) patients, a sonographic examination was
performed immediately after surgery. In 29/50 (58%) pa-
tients, there were no more cysts, in 21/50 (42%) patients,
remaining cysts have been observed. The total cysts vol-
ume had been reduced on average by 47% (6%-85%)
through surgery in patients with remnant cysts.
Sonographic follow-up examination
The mean follow-up period was 43 months (3–119 months).
46/56 (82%) patients had a sonographic follow-up examin-
ation. Only 2/46 (4%) patients had no sonographic evidence
of cysts. 11/46 (24%) patients had single and 33/46 (72%)
patients had multiple cysts (including 3 patients with
PCLD). There was cyst-related hepatomegaly in 15/46
(33%) patients. Only 3 patients with remaining cysts did
not have any clinical complaints. In 8 patients, the size of
the cysts had increased as compared to the immediate
post-operative examination.
Symptoms and recurrence rate during follow-up
23/46 (50%) patients were completely symptom-free and
23/46 (50%) patients had persisting symptoms. 3/23 (13%)
patients with persisting symptoms had no symptom
change in the pre-/post-operative comparison, whereas
12/23 (52%) patients had increasing and 8/23 (35%) pa-
tients decreasing symptoms (Table 4). The post-operative
symptoms included feeling of pressure (33%), upper ab-
dominal pain (24%), fullness (15%), dyspnoea (15%), nau-
sea (13%), early satiety (11%) and weight loss (2%; multiple
answers possible). In 3/8 (38%) of the patients with de-
creased symptoms there was probably an association with
a new cyst (5 cm, 7 cm and 11 cm, respectively). In 7/12(58%) of the patients with increased symptoms relevant
cysts have been observed (5–20 cm, average cyst size
9 cm). In one of these patients the increasing clinical com-
plaints were most likely caused by a symptomatic inci-
sional hernia. In the 3 patients with identical symptoms
pre- and post-operatively, there might have been an asso-
ciation with a new cyst of 5 cm in size and in one case this
was probable for a cyst of 15.5 cm. Therefore in altogether
12/23 (52%) patients with persisting or increasing symp-
toms this may generally be explained by a new cyst (8 of
these 12 patients with a new cyst had a cyst size of at least
6 cm). Recurrences developed in 13/46 (28.3%) patients. 4
of those (4/46, 8.7%) have been “true surgical” recurrences
at the former surgical site. All recurrences occurred after
laparoscopic fenestration. There was, however, no signifi-
cant association between recurrence and surgical tech-
nique (p = 0.562). 3 patients did have further surgery for
liver cysts during the follow-up period. There was one
open surgical revision (adhesions/stenosis of the gastro-
duodenal junction) and 2 laparoscopic re-operations. The
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the surgical techniques with respect to the number
of reported clinical complaints. The decrease of the num-
ber of symptoms post-operatively as compared to pre-
operatively was significant after laparoscopic surgery (p =
0.004) but did not improve after open or conversion
surgery (p = 0.667 and p = 1.000, respectively).
Symptoms and description of the quality of life
7/46 (15%) patients reported their current health condi-
tion as being very good while 24/46 (52%) patients
reported it as being good. 15/46 (33%) reported their
current health condition as constricted, 13 of these 15
patients felt impaired in their daily lives by the reported
symptoms. On a scale from 0–10, 33/46 (72%) patients
did not report any impairment (0). 6/46 (13%) patients
reported minor impairment (grade 1–3) and 7/46 (15%)
patients reported moderate to major impairment (grade
4–8). 13/33 (39%) patients with an impairment degree of
0 in their daily lives did report at least 1 symptom in
their history of clinical complaints.
Discussion
For SLCs cyst deroofing (laparoscopic wherever possible)
is considered as being the therapeutic gold standard. The
symptoms in patients with liver cysts are non-specific. Die
Zystengröße allein scheint eine untergeordnete Rolle zu
spielen, da selbst bei großen kongenitalen Leberzysten
asymtpmatische Verläufe keine Seltenheit sind [3]. It is
certain that other factors play a role, in particular the loca-
tion of the cysts. So far, in the literature, there are hardly
any considerations of psychosomatic factors that may play
a role in a certain patient proportion which may be diffi-
cult to identify; these factors are complex and difficult to
measure.
For reasons of clarity of the terminology and because
of the fact that too small a fenestration may favour re-
currence, the term complete cyst deroofing should be
used in order to emphasize this aspect [3,12].
The value of the current study is in its rather concise
follow-up (clinical examination, sonography, question-
naire) in a sufficiently large patient population and long
follow-up period. Our patient population is comparable
to those of other groups on the topic with respect to
age, gender distribution, cyst size, symptoms and com-
plication rate [2,10,13]. Studies with more than 50 pa-
tients and a specific follow-up are scarce [2,10,11,13,14].
A sufficiently long follow-up period is of critical import-
ance in patients with liver cysts because there is evi-
dence that a relatively large patient proportion (5-50%
according to the literature) develops recurrent clinical
symptoms from cysts within 3–5 years [2]. The mean
follow-up period in this current study is 43 months. This
duration was reached or surpassed in only half of thestudies published so far [2]. There are only scarce exact
comparisons of pre- and post-operative symptoms in the
literature [2,11].
Our altogether recurrence rate is as high as 28.3%. For
principal reasons in our opinion the type of recurrence
(i.e. a “true surgical recurrence” at the former surgical
site vs. a “recurrence of the disease” in terms of com-
pletely new or enlarged pre-existing cysts) should be
considered as different entities in an analysis of surgical
outcome. This discrimination can only be made by an
accurate imaging during the follow-up and will not be
done in the daily routine. Split like this our surgical re-
currence rate was 8.7% and recurrent disease occurred
in 19.6%, both rates being independent of the surgical
approach.
Our study includes 4 patients with PCLD. Cyst
deroofing (possibly laparoscopically) in Gigot stage I
may provide a long lasting improvement. The recurrence
rate in PCLD is generally higher, and more frequently
liver resection is the treatment of choice [2]. Thus, there
is a fundamental difference between SLC/PCLD stage I
and PCLD stage II/III. In cases of diffuse disease, re-
duced nutritional status, extreme hepatomegaly and as-
cites, liver transplantation may be considered (in cases
of GFR < 40 ml/min with simultaneous kidney trans-
plantation) [15].
As in selected patients with PCLD the decision for re-
section or deroofing may be made, these cases were
primarily included in the analysis. However, numerous
reports in the literature suggest that patients with PCLD
should be analyzed separately. Even though our 4 pa-
tients with PCLD should not have falsified our results
significantly, we would strictly separate these two en-
tities in future studies.
In all studies, females predominate (1:3 – 1:9)
[2,10,12,13]. The age peak is around 60 years, as it is in
our patient population. Between the age of 30 and
60 years, there is a progressive growth of cysts for rea-
sons that are not known so far [16]. Several authors have
linked this to the influence of estrogens [17]. In our pa-
tient population, we did not observe a significant associ-
ation between female sexual hormones and symptoms or
cyst size.
16/56 (29%) of our patients underwent simultaneous
cholecystectomy for concomitant cholecystolithiasis or
immediate proximity of the gallbladder to the cyst (8 open,
8 laparoscopically; 6 concomitant cholecystolithiasis, 9 im-
mediate proximity, 1 concomitant cholecystolithiasis and
immediate proximity).
The decision for surgery was based on the liver cyst
even though it is not possible to clarify definitively if in
case of concomitant gall stones the reported symptoms
may be attributed to these (none of these patients did
show typical signs of gall stone related disease, such as
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teria or typical symptoms in the medical history). In case
of gall stones, we generally perform a cholecystectomy
simultaneously at our institution, except in cases where
the patients decides otherwise.
In 84% of the patients, the cyst deroofing was started
as a laparoscopic procedure, the conversion rate was
6.4%. There was previous abdominal or gynaecological
surgery in 73% and 49%, respectively, while only in one
case the previous abdominal surgery (Billroth-II resec-
tion) was the reason for a primary open procedure. In a
total of 9 cases, the surgical procedure was primarily
open (3 unfavorable cyst locations, 2 vena cava throm-
boses, 1 PCLD, 1 recurrence, 1 abscess, 1 Billroth-II re-
section). As reported in the literature, this approach was
reserved for particular situations. In both cases of a con-
comitant vena cava thrombosis, successful thrombec-
tomy was performed.
Three fourths of the patients were ASA stage II and
almost one tenth were stage III. This explains the com-
paratively long hospital stay of 6 and 8 days, respectively
(laparoscopic and open group, respectively).
In the literature, there are occasional reports about
predominant affection of the right or left lobe. We could
not confirm that observation in our patient population.
In one third of our patients with laparoscopic surgery,
segments IVa, VII and VIII were affected; access to these
is considered to be difficult. This is as such not a contra-
indication against the laparoscopic approach, neither did
it affect the conversion rate in a negative way. We be-
lieve that this confirms the experience of other authors,
that this problem is met by an on-going learning curve
on one hand and by specific patient positioning (modi-
fied left sided position) as required on the other hand.
In the laparoscopy group, the intra-operative complica-
tion rate was 17% (possibly related to the learning curve)
while it was 0% in the laparotomy group (difference not
significant). Those were mainly bleeding complications
which led to conversion in 2 cases. The post-operative
complication rate of 16% was within the data reported in
the literature. 3 cases (Clavien-Dindo grade IIIa) required
intervention for bile leakage (sonographically guided drain-
age and/or ERC). The difference in the post-operative
complication rate (laparoscopy vs. laparotomy 13% vs.
33%) was significant but does reflect in general the selec-
tion of “more difficult” patients for open surgery.
The use of omentoplasty is being discussed controver-
sially in the literature. We have employed it in 14% of
our patient population (8/56; 5 laparoscopically, 3 open).
None of our patients with omentoplasty developed a
recurrence. However, in one case, there was intra-
operative bleeding from the omentum majus during lap-
aroscopic omentoplasty; this did not necessitate conver-
sion. Because of the few cases of omentoplasty in ourpatient population, we cannot make a definitive state-
ment. There are reports about recurrence in the litera-
ture despite omentoplasty [10,18]. Furthermore, there is
evidence that omentoplasty may cause additional com-
plications or favour recurrence [10,19]. The data in the
literature are controversial and there as many propo-
nents as opponents of omentoplasty [2,9,10,18-21] while
in more recent publications the value of omentoplasty is
being viewed critically [10,18,19,21]. Currently, a falci-
form ligament pedicle graft is being proposed as an al-
ternative prophylaxis against recurrence, but there are
no long-term data available so far [22].
Half of our patient population (23/46, 50%) were com-
pletely symptom-free after cyst deroofing. The other half
reported persisting symptoms. Only in some of these pa-
tients a new cyst is the explanation for the reported
complaints.
This high rate may be explained by the design of the
interview. 11 symptoms, possibly related to liver cysts,
have been included in the interview. As soon as even only
one of the 11 possible symptoms was reported in the post-
operative interview, this was declared as persistent clinical
complaints. In retrospect, this interview design is un-
specific. Finally, the liberal decision for surgery may be an
explanation as symptoms which may have had other
causes may have not been decisively clarified and may
have been falsely attributed to liver cysts. It may be benefi-
cial to assess the psychosomatic aspects separately in
order to relate them to the respective somatic complaints.
Our work also suggests that un-specific symptoms
may have been judged too un-critically as being the
cause of clinical complaints and, thus, have been judged
to be relevant for the decision making (Table 3). The as-
sociation between cyst location and the specific com-
plaints should possibly have been established more
precisely and only a very obvious association should lead
to surgery (e.g. a relatively large cyst exerts pressure on
the gastro-duodenal junction). We will, thus, perform
more intensive diagnostics (in particular endoscopically)
of the vicinity in the future in order to rule out con-
comitant disease. Furthermore, we consider the intro-
duction of the cyst aspiration test in the future for better
patient selection.
Irrespective of the accuracy of the follow-up, a recur-
rence rate of approximately 5% and an associated
reoperation rate of less than 10% may be assumed
[2,23,24]. As opposed to earlier reports in the literature
[3,25], our data and numerous other studies show, that
the laparoscopic procedure as such is no longer a risk
factor for a higher probability of recurrence [2,11,13].
Carrying a low rate of complications and conversions, it
is, thus, to be considered the treatment of choice for the
vast majority of cases. In our study, we have mainly used
the ultrasound dissector in the laparoscopically treated
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the recurrence rate with the dissection technique. How-
ever, the development of recurrence is supposedly more
affected by the extent of the fenestration/deroofing (and,
thus, only indirectly by the dissection technique) [10,26].
Several groups report the avoidance of cyst recurrence
after an ablation of the cyst lining in the residual fenes-
trated cystic cavity with argon beam coagulation [25,27].
We have used this technique so far only for liver resec-
tions. The results with argon beam coagulation to the
cyst lining in the literature appear to be promising so
that we will use it in the future in order to avoid cyst
recurrence.
Conclusions
In conclusion, our results, in context with the data from
the literature may be summed up as follows: only symp-
tomatic cysts should be operated. True/symptomatic re-
currence develops in 5% to maximally 10% of patients.
Recurrences will become most probably symptomatic
again. In approximately one fifth of patients new cysts
develop or existing cysts grow. It is currently not clear
under which circumstances such conditions become
symptomatic. In our study in one half of the patients the
symptoms continued at varying degrees. In order to ad-
dress this point appropriately, a more extensive diag-
nostic work-up and a meticulous patient selection are
necessary in our hands. With respect to QoL, our results
provide only very general information. Two thirds of the
overall patients reported their post-operative health as
being good or very good.
So far, the literature does not distinguish strictly be-
tween true recurrence (i.e. a new cyst exactly at the loca-
tion where surgery was performed) and remaining cysts
that grow in due course or de-novo symptomatic cysts.
For the sake of better comparability of study results, a
standardized follow-up (including sonography on a regular
basis) as well as a sufficiently long follow-up period of at
least 3 years are required. In adequately selected patients,
laparoscopic (or open) deroofing is nevertheless the most
effective treatment option for symptomatic patients. Our
data may be limited by the retrospective character of our
analysis. The above mentioned questions and particular-
ities require further scientific evaluation.
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